Menu
Enrolling by invitation NCT06837870

Percutaneous Closure Versus Figure-of-eight Suture for Hemostasis in Leadless Pacemaker Implantation.

No phase Interventional Vascular Closure Pacemaker Implantation Leadless Pacemaker

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: percutaneous suture mediated closure, Figure of Eight Suture.
Who it may be relevant to
Registry conditions: Vascular Closure, Pacemaker Implantation, Leadless Pacemaker. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Randomized Comparison of Percutaneous Closure to a Figure-of-eight Suture With Manual Compression for Hemostasis of Large-bore Access for Leadless Pacemaker Implantation

Overview

The study will be a randomized comparison of percutaneous suture-mediated closure (SMC) versus manual compression with a superficial figure-of-eight suture (MC) for large bore venous access used for leadless pacemaker implantation.

Interventions

  • Device percutaneous suture mediated closure
    Vascular closure with a commercially available SMC device.
  • Device Figure of Eight Suture
    Manual Compression with Figure of Eight Suture (control).

Primary outcome measures

  • Time to Hemostasis [Time frame: During the procedure.]
Secondary outcome measures (5)
  • Time to discharge eligibility [Time frame: Periprocedurally, from day 0 up to discharge; typically 0-1 days but up to the time of hospital discharge.]
  • Major access related complications [Time frame: 0 and 30 days]
  • Minor access related complications [Time frame: 0 and 30 days]
  • Patient reported outcomes [Time frame: 0 and 30 days]
  • Costs [Time frame: 0 and 30 days]

Eligibility criteria

Inclusion criteria

  • Patients aged 18 and older
  • Patients undergoing leadless pacemaker implant at UMass Chan Medical Center
  • Subjects able to understand and provide written informed consent.

Exclusion criteria

  • Patients who are pregnant
  • Patents who are not able to ambulate prior to the procedure
  • Other conditions that, in the opinion of the investigator constitute a risk or contraindication for participation in the study or that could interfere with the study objectives, conduct or evaluation
  • Prisoners or wards of the state.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • UMass Chan Medical School — Worcester

Identifiers

NCT: NCT06837870 · STUDY00002172

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗